Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jan;95(1):10-3.
doi: 10.1111/j.1365-2249.1994.tb06007.x.

Failure in IgA secretion by surface IgA-positive B cells in common variable immunodeficiency (CVID)

Affiliations

Failure in IgA secretion by surface IgA-positive B cells in common variable immunodeficiency (CVID)

L J Scott et al. Clin Exp Immunol. 1994 Jan.

Abstract

CVID is an acquired disease with low serum immunoglobulins. Patients are classified into three groups on the ability of their B cells to secrete IgM and IgG in vitro in response to IL-2. We have now extended this patient classification to include IgA secretion and to assess whether the patients have IgA+ B cells in the circulation. B cells from almost all of the CVID patients studied were unable to secrete any IgA in vitro, with or without IL-2, although all B cells tested from normal donors showed some spontaneous IgA secretion. Thus, the defect with IgA secretion is more profound than with the secretion of IgM or IgG. Despite this failure to secrete IgA, using flow cytometry techniques all CVID patients tested were found to have IgA+ cells (expressed as a percentage of B cells) within the normal range. This suggests that CVID may involve a defect in the secretion of immunoglobulin isotypes rather than a defect in isotype switching.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Immunol Immunopathol. 1989 May;51(2):196-204 - PubMed
    1. Clin Immunol Immunopathol. 1973 Jan;1(2):241-56 - PubMed
    1. Transplant Rev. 1973;16:85-113 - PubMed
    1. Clin Exp Immunol. 1980 Dec;42(3):535-44 - PubMed
    1. Immunol Invest. 1991 Apr;20(2):143-50 - PubMed

MeSH terms